A new intestinal supplement ‘Synbiotics’ therapeutically regulates gut microbiota and activates PPARs pathway to inhibit Alzheimer’s disease progression in mouse models
New Microbiol. 2024 May;47(1):68-79.ABSTRACTWe aimed to investigate the role of Synbiotic preparations on the interaction of gut microbiota with AD development. APP/PS1 mice were randomized...